Clinical trial
Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
NCT00003558 · Academisch Ziekenhuis Maastricht, Other · Unknown status
Key facts
| NCT number | NCT00003558 |
|---|---|
| Title | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin |
| Official title | A Randomized Phase III Trial of Paclitaxel, Carboplatin and Etoposide Vs. 5-Fluorouracil and Folinic Acid in the Treatment of Patients With Adenocarcinoma of Unknown Primary Site |
| Lead sponsor | Academisch Ziekenhuis Maastricht, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma of Unknown Primary |
| Intervention type | Drug |
| Interventions | carboplatin, etoposide, fluorouracil, leucovorin calcium, paclitaxel |
| Enrollment | 140 |
| Start date | Aug 1, 1998 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: